On August 25, 2026 Oxcia AB reported interim results for the second quarter 2026. Oxcia’s financial reports are only available in Swedish. They can be found Finansiella rapporter – Oxcia and Pressmeddelanden Archives – Oxcia.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

For more information contact:

Ulrika Warpman Berglund, CEO, Oxcia AB (publ)

Telephone: +46 (0) 73 270 9605
[email protected]

(Press release, Oxcia, AUG 25, 2026, View Source;utm_medium=rss&utm_campaign=oxcia-ab-publ-publishes-interim-report-for-the-second-quarter-2026 [SID1234670315])